Patient Dies: Biogen, Elan Halt MS Drug (Reuters)


Reuters - Biogen Idec and Elan Corp.
Plc on Monday suspended sales of their
much-heralded new multiple sclerosis drug Tysabri after a
patient died from a rare and often fatal infection of the
central nervous system.

Read more...